Illumaxbio, founded in August 2018, is committed to achieving the whole chain control through core innovation and providing cost-effective clinical immunoassay and molecular diagnostic systems for clinic. Illumabio strive to become an innovator in the global in vitro diagnosis segment in the next 10 years.

The founding team of Illumaxbio has been working in the IVD industry for many years, with strong research & development ability and industrialization ability. By breaking through the upstream core components, integrating cutting-edge technology, and precise market positioning, we achieve diversified competition and provide customers with 5A (Anytime, Anyplace, Anyone, Affordable, Accuracy) products.